Chandan Healthcare's Q3 FY 2025-26 Quarterly Results
- 15 Feb 2026
Result Summary
- Chandan Healthcare Ltd reported a - quarter-on-quarter (QoQ) - in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 16.3%.
- Its expenses for the quarter were - by - QoQ and up 17.1% YoY.
- The net profit - - QoQ and increased 3.5% YoY.
- The earnings per share (EPS) of Chandan Healthcare Ltd stood at 1.86 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 65.77 | 0.00 | 56.55 | - | 16.3% |
Total Expenses | 56.85 | 0.00 | 48.53 | - | 17.1% |
Profit Before Tax | 6.69 | - | 8.01 | NaN% | -16.5% |
Tax | 1.66 | 0.00 | 1.88 | - | -11.7% |
Profit After Tax | 5.03 | 0.00 | 4.86 | - | 3.5% |
Earnings Per Share | 1.86 | 0.00 | 0.00 | - | - |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Chandan Healthcare Ltd is a company operating within the healthcare sector, which typically involves the manufacturing and distribution of pharmaceutical products, medical devices, or health-related services. However, specific information about Chandan Healthcare Ltd’s main products, services, or recent major developments is not available from the data provided. The healthcare industry, in general, is known for its critical role in improving health standards and supporting public health needs. Companies in this sector often experience fluctuations in demand due to factors such as healthcare policies, technological advancements, and changes in population health trends.
Revenue
In the third quarter of the fiscal year 2026 (Q3FY26), Chandan Healthcare Ltd reported a total income of ₹65.77 crores. This represents a year-over-year (YoY) increase of 16.3% from the ₹56.55 crores reported in the same quarter of the previous year (Q3FY25). The quarter-over-quarter (QoQ) comparison is not available as the total income for the second quarter of fiscal year 2026 (Q2FY26) is not provided. The growth in total income could indicate an increase in demand for the company’s products or services during this period.
Profitability
Chandan Healthcare Ltd's profitability metrics for Q3FY26 show that the company recorded a Profit Before Tax (PBT) of ₹6.69 crores, which is a decrease of 16.5% YoY from ₹8.01 crores in Q3FY25. The tax paid was ₹1.66 crores, compared to ₹1.88 crores in the same quarter last year, reflecting a decrease of 11.7% YoY. Consequently, the Profit After Tax (PAT) for Q3FY26 was ₹5.03 crores, marking a 3.5% increase YoY from ₹4.86 crores in Q3FY25. Earnings Per Share (EPS) for this quarter was reported at ₹1.86, although no comparative data is available for previous quarters or years.
Operating Metrics
The total expenses for Chandan Healthcare Ltd in Q3FY26 amounted to ₹56.85 crores, which reflects a 17.1% increase YoY from ₹48.53 crores in Q3FY25. This increase in expenses, alongside the income growth, could be indicative of expanded operations or increased input costs. No QoQ data is available to analyze the immediate past quarter's spending. The absence of financial ratios such as P/E ratio, debt-to-equity ratio, or current ratio in the data limits further insights into the company's operational efficiency and financial health. The provided data does not include a direct calculation of these ratios or the components needed to derive them.